Afghanistan has observed a 0.2% (0.6%) increase in the female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70, which now stands at 36.2%.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Afghanistan
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Afghanistan
Female CVD, cancer, diabetes or CRD
More indicators for Afghanistan
Out-of-pocket expenditure PPP per capita
intl dollar281
+intl dollar39
(2021)
Newborns protected against tetanus
60%
-5%
(2022)
Female wasting in children
3.5%
-0.6%
(2022)
Birth registration
42.3%
+4.9%
(2015)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
19.8%
0%
(2016)
Afghanistan Female CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Female CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 36.2% | +0.2% |
| 2018 | 36% | +0.1% |
| 2017 | 35.9% | -0.1% |
| 2016 | 36% | +0.3% |
| 2015 | 35.7% | 0% |
| 2014 | 35.7% | -0.4% |
| 2013 | 36.1% | -0.2% |
| 2012 | 36.3% | -0.5% |
| 2011 | 36.8% | -0.6% |
| 2010 | 37.4% | -0.4% |
| 2009 | 37.8% | -1.1% |
| 2008 | 38.9% | -0.6% |
| 2007 | 39.5% | -0.3% |
| 2006 | 39.8% | -0.2% |
| 2005 | 40% | -0.2% |
| 2004 | 40.2% | +0.1% |
| 2003 | 40.1% | -0.4% |
| 2002 | 40.5% | +0.4% |
| 2001 | 40.1% | +0.7% |
| 2000 | 39.4% |